May 17, 2020

Celebrity fad or medical marvel

London 2012
Kinesio
Kinesio tape
Olympics
Admin
2 min
Either a medical marvel or a convenient placebo, Kinesio tape is the latest fad in the sporting world
First we saw Mario Balotelli exhibiting his go-faster stripes as he whipped off his shirt in Euro 2012. Then it was world number one seed Novak Djokovi...

First we saw Mario Balotelli exhibiting his go-faster stripes as he whipped off his shirt in Euro 2012. Then it was world number one seed Novak Djokovic sporting an elbow patch at Wimbledon. So what is the purpose of this new fangled blue tape?

Kinesio tape as it is known was the brainchild of Japanese scientist Dr Kenzo Kase, and has actually been around since the 1970s. The makers claim that the strips of blue tape give athletes the edge by mending and preventing injuries.

Conventional strapping techniques are derived from rehabilitation strapping, often tending to isolate a joint or muscle and prevent or reduce movement. This can be very restrictive in a sporting environment and actually hinder performance.

The benefit of extra movement is clear in a performance sense, however there is very little medical evidence proving the effectiveness of Kinesio tapes healing power, likewise however, Professor John Brewer from the University of Bedfordshire “can’t see it would cause any real problem, other than making you loose a few hairs”.

The manufacturers of the tape claim that it assist with the lymphatic flow under the skin, reducing swelling and in turn pain. This allows greater mobility and faster healing time.

To read the latest edition of Healthcare Global, click here

There has been some argument that the tape may serve a purpose as a placebo, reassuring players that they are on the mend, or that they are less susceptible to injury. There has been considerable research into the power of the mind, and it is plausible that Kinesio tape is catching on because of its psychological benefits.

John Brewer continued by saying: "Personally, I think it is more of a placebo effect. There is no firm scientific data to show that it has an impact on performance or prevents injuries. My concern is that there is little that you can put on the skin that will have a real benefit for the muscles that lie deep beneath. The power and stress going through the joints is immense.

Whether the magic blue tape holds any real medical benefits remains to be seen, however placebo or not, I am sure that we will be seeing a lot more of this latest sporting craze as London 2012 comes rolling round the corner. And who could blame an athlete at the top of their career utilising every benefit, perceived or not, to go for gold.

Visit Kinesio tape global here

Visit Kinesio tape UK here

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article